Logo for Sino Biopharmaceutical Limited

Sino Biopharmaceutical Investor Relations Material

Latest events

Logo for Sino Biopharmaceutical

H1 2024

13 Aug, 2024
Logo for Sino Biopharmaceutical

H2 2023

28 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Sino Biopharmaceutical Limited

Access all reports
Sino Biopharmaceutical Limited is a Chinese pharmaceutical company focused on the research, development, manufacturing, and distribution of a wide range of pharmaceutical products. The company’s portfolio covers therapeutic areas such as oncology, hepatitis, cardiovascular, orthopedics, and respiratory diseases. Sino Biopharmaceutical emphasizes innovation through its research and development efforts, producing both innovative and generic drugs to meet healthcare needs in China and internationally. The company is headquartered in Beijing, China, and its shares are listed on the Hong Kong Stock Exchange.